✦ LIBER ✦

OC.04.5 A MODEL TO PREDICT SUCCESS FOLLOWING PEG-INTERFERON AND RIBAVIRIN THERAPY FOR PATIENTS WITH HCV-1 INFECTION

✍ Scribed by Ippolito, A.M.; Andriulli, A.; Angelico, M.; Nardi, A.; Di Marco, V.; Smedile, A.; Calvaruso, V.; Valvano, M.R.; Milella, M.; Morisco, F.; Fattovich, G.; Felder, M.; Brancaccio, G.; Fasano, M.; Gatti, P.; Andriulli, N.; Tundo, P.; Barone, M.; Cozzolongo, R.; D'Andrea, G.; Mazzella, G.; Santantonio, T.

Book ID: 122211385
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 95 KB
Volume: 46
Category: Article
ISSN: 1590-8658
DOI: 10.1016/S1590-8658(14)60032-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estimates of HCV-1 Patients Attaining RV

Estimates of HCV-1 Patients Attaining RVR Following Dual Therapy with Peg-Interferon and Ribavirin

✍ Andriulli, A.; Iacobellis, A.; Valvano, M. R.; Spirito, F.; Ippolito, A.; Bossa, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 572 KB

P1128 A MODEL TO ESTIMATE A PRIORI THE P

P1128 A MODEL TO ESTIMATE A PRIORI THE PROBABILITY OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-INTERFERON AND RIBAVIRIN FOR PATIENTS WITH HCV-1 INFECTION

✍ Andriulli, A.; Angelico, M.; Nardi, A.; Ippolito, A.M.; Gravila, C.; Calvaruso, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 68 KB

1086 A SUBSTANTIAL PROPORTION OF NAIVE H

1086 A SUBSTANTIAL PROPORTION OF NAIVE HCV-1 INFECTED PATIENTS WITH CHRONIC INFECTION MAY BENEFIT FROM CURRENT STANDARD THERAPY WITH PEG-INTERFERON AND RIBAVIRIN

✍ Andriulli, A.; Valvano, M.R.; Spirito, F.; Ippolito, A.; Iacobellis, A.; Bossa, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

499 VERY-EARLY VIRAL RESPONSE (WEEK-1) T

499 VERY-EARLY VIRAL RESPONSE (WEEK-1) TO TRIPLE THERAPY WITH TELAPREVIR, PEG-INTERFERON AND RIBAVIRIN PREDICTS EXTENDED-RVR AND TREATMENT OUTCOMES IN PATIENTS WITH HCV GENOTYPE 1

✍ Takaguchi, K.; Toyota, H.; Seno, T.; Baba, N.; Nagano, T.; Kumada, T.; Kato, K.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Mutation frequency of NS5A in patients v

Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy

✍ A. C. W. Jenke; S. Moser; V. Orth; M. Zilbauer; P. Gerner; S. Wirth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

1166 CLINICAL RELEVANCE OF MINIMAL RESID

1166 CLINICAL RELEVANCE OF MINIMAL RESIDUAL VIREMIA DETECTED WITH THE ABBOTT REALTIME HCV ASSAY FOR RESPONSE-GUIDED THERAPY WITH PEG-INTERFERON-a/RIBAVIRIN IN PATIENTS WITH HEPATITIS-C-VIRUS GENOTYPE 1 INFECTION

✍ Vermehren, J.; Süsser, S.; Perner, D.; Füller, C.; Zeuzem, S.; Sarrazin, C. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB